Literature DB >> 27657467

Accuracy of administrative data for identification of patients with infective endocarditis.

Charlie Tan1, Mark Hansen2, Gideon Cohen3, Karl Boyle4, Nick Daneman5, Neill K J Adhikari6.   

Abstract

BACKGROUND: Infective endocarditis is associated with high morbidity and mortality rates that have plateaued over recent decades. Research to improve outcomes for these patients is limited by the rarity of this condition. Therefore, we sought to validate administrative database codes for the diagnosis of infective endocarditis.
METHODS: We conducted a retrospective validation study of International Classification of Diseases (ICD-10-CM) codes for infective endocarditis against clinical Duke criteria (definite and probable) at a large acute care hospital between October 1, 2013 and June 30, 2015. To identify potential cases missed by ICD-10-CM codes, we also screened the hospital's valvular heart surgery database and the microbiology laboratory database (the latter for patients with bacteremia due to organisms commonly causing endocarditis).
RESULTS: Using definite Duke criteria or probable criteria with clinical suspicion as the reference standard, the ICD-10-CM codes had a sensitivity (SN) of 0.90 (95% confidence interval (CI), 0.81-0.95), specificity (SP) of 1 (95% CI, 1-1), positive predictive value (PPV) of 0.78 (95% CI, 0.68-0.85) and negative predictive value (NPV) of 1 (95% CI, 1-1). Restricting the case definition to definite Duke criteria resulted in an increase in SN to 0.95 (95% CI, 0.86-0.99) and a decrease in PPV to 0.6 (95% CI, 0.49-0.69), with no change in specificity.
CONCLUSION: ICD-10-CM codes can accurately identify patients with infective endocarditis, and so administrative databases offer a potential means to study this infection over large jurisdictions, and thereby improve the prediction, diagnosis, treatment and prevention of this rare but serious infection.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Administrative data; Infective endocarditis; Validation

Mesh:

Year:  2016        PMID: 27657467     DOI: 10.1016/j.ijcard.2016.09.030

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  18 in total

1.  Positive Predictive Value of Administrative Data for Neonatal Abstinence Syndrome.

Authors:  Faouzi I Maalouf; William O Cooper; Shannon M Stratton; Judith A Dudley; Jean Ko; Anamika Banerji; Stephen W Patrick
Journal:  Pediatrics       Date:  2018-12-04       Impact factor: 7.124

2.  The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis.

Authors:  Matthew A Weir; Justin Slater; Racquel Jandoc; Sharon Koivu; Amit X Garg; Michael Silverman
Journal:  CMAJ       Date:  2019-01-28       Impact factor: 8.262

3.  Risk of Infective Endocarditis in Patients with End Stage Renal Disease.

Authors:  Mavish S Chaudry; Nicholas Carlson; Gunnar H Gislason; Anne-Lise Kamper; Marianne Rix; Vance G Fowler; Christian Torp-Pedersen; Niels E Bruun
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-03       Impact factor: 8.237

4.  Clinical risk factors for acute ischaemic and haemorrhagic stroke in patients with infective endocarditis.

Authors:  Ives Valenzuela; Madeleine D Hunter; Kathryn Sundheim; Bradley Klein; Lauren Dunn; Robert Sorabella; Sang M Han; Joshua Willey; Isaac George; Jose Gutierrez
Journal:  Intern Med J       Date:  2018-09       Impact factor: 2.048

5.  Positive predictive value of infective endocarditis in the Danish National Patient Registry: a validation study.

Authors:  Lauge Østergaard; Kasper Adelborg; Jens Sundbøll; Lars Pedersen; Emil Loldrup Fosbøl; Morten Schmidt
Journal:  Epidemiol Infect       Date:  2018-05-30       Impact factor: 4.434

6.  The impact of hemodialysis on mortality risk and cause of death in Staphylococcus aureus endocarditis.

Authors:  Mavish S Chaudry; Gunnar H Gislason; Anne-Lise Kamper; Marianne Rix; Anders Dahl; Lauge Østergaard; Emil L Fosbøl; Trine K Lauridsen; Louise B Oestergaard; Christian Hassager; Christian Torp-Pedersen; Niels E Bruun
Journal:  BMC Nephrol       Date:  2018-09-03       Impact factor: 2.388

7.  Use of Vasoactive Medications after Cardiac Surgery in the United States.

Authors:  Emily A Vail; Meng-Shiou Shieh; Penelope S Pekow; Hayley B Gershengorn; Allan J Walkey; Peter K Lindenauer; Hannah Wunsch
Journal:  Ann Am Thorac Soc       Date:  2021-01

8.  Validity of ICD-based algorithms to estimate the prevalence of injection drug use among infective endocarditis hospitalizations in the absence of a reference standard.

Authors:  Kaitlin M McGrew; Hélène Carabin; Tabitha Garwe; S Reza Jafarzadeh; Mary B Williams; Yan Daniel Zhao; Douglas A Drevets
Journal:  Drug Alcohol Depend       Date:  2020-03-04       Impact factor: 4.852

9.  Case conferences for infective endocarditis: A quality improvement initiative.

Authors:  Charlie Tan; Mark S Hansen; Gideon Cohen; Karl Boyle; Alvin Yang; Asgar Rishu; Ruxandra Pinto; Neill K J Adhikari; Nick Daneman
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

10.  Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis.

Authors:  Charlie Tan; Esfandiar Shojaei; Joshua Wiener; Meera Shah; Sharon Koivu; Michael Silverman
Journal:  JAMA Netw Open       Date:  2020-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.